Michael L. Terrin

Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction

Edwin G. Bovill, Michael L. Terrin, David C. Stump et al. · Annals of Internal Medicine · 1991 · 485 citations

Medicine, Cardiology, Pharmacotherapy +17

Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: Results of thrombolysis in myocardial infarction (TIMI) phase II study

Barry L. Zaret, Frans J. Th. Wackers, Michael L. Terrin et al. · Journal of the American College of Cardiology · 1995 · 146 citations · Full text

Medicine, Cardiology, Nuclear Medicine +17

Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial

Michael L. Terrin, David O. Williams, Neal S. Kleiman et al. · Journal of the American College of Cardiology · 1993 · 76 citations

Medicine, Cardiology, Clinical Cardiology +10

Coronary artery bypass graft surgery after thrombolytic therapy in the thrombolysis in myocardial infarction trial, Phase II (TIMI II)

Bernard J. Gersh, James H. Chesebro, Eugene Braunwald et al. · Journal of the American College of Cardiology · 1995 · 30 citations

Medicine, Cardiology, Surgery +17